Our Research

Our research is driven by the aim of developing “one shot” eye therapies suitable for curing blinding or fatal eye diseases in low resource settings.  With this in mind, we concentrate on developing

  1. Intraocular gene therapy for macular degeneration which can be given in a once off injection
  2. Diabetic retinopathy diagnosis and treatments with existing medications and lasers
  3. Cancer gene therapy for treatment of eye melanoma

Researcher profile: Dr Sean Jenkins

September 11, 2017

Sean is a postdoctorate clinical researcher in the Ophthalmology Research Unit working under A/Professor Layton’s supervision. He trained in scientific...